gadolinium oxide has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, T; Wang, L; Xiao, X; Zhao, E; Zhou, X | 1 |
| Chen, S; Huang, W; Jin, H; Li, Y; Sui, Y; Zheng, Y | 1 |
| Chen, W; Jin, X; Li, F; Li, P; Li, Q; Li, Z; Liu, Y; Shen, Z; Wu, A; Zhang, P | 1 |
3 other study(ies) available for gadolinium oxide and Lung Neoplasms
| Article | Year |
|---|---|
Clinical practice of epidermal growth factor receptor-tyrosine kinase inhibitor targeted drugs combined with gadolinium oxide nanoparticles in the treatment of non-small cell lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Drug Resistance, Neoplasm; Drug Synergism; Female; Gadolinium; Humans; Hyaluronic Acid; Lung Neoplasms; Male; Middle Aged; Nanoparticles; Neoplasm Staging; Particle Size; Protein Kinase Inhibitors; Radiotherapy, Conformal; Random Allocation; Survival Analysis; Treatment Outcome | 2022 |
Tumor-specific design of PEGylated gadolinium-based nanoscale particles: Facile synthesis, characterization, and improved magnetic resonance imaging of metastasis lung cancer.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Contrast Media; Cysteine; Gadolinium; Hemolysis; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Melanoma, Experimental; Mice; Nanoparticles; Polyethylene Glycols; RAW 264.7 Cells; Transplantation, Homologous | 2020 |
Ultra-small gadolinium oxide nanocrystal sensitization of non-small-cell lung cancer cells toward X-ray irradiation by promoting cytostatic autophagy.
Topics: Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Cell Survival; DNA Damage; Endocytosis; Gadolinium; Humans; Hydroxyl Radical; Lung Neoplasms; Nanoparticles; Oxidative Stress; Particle Size; X-Rays | 2019 |